Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein

被引:41
作者
Ho, N
Punturieri, A
Wilkin, D
Szabo, J
Johnson, M
Whaley, J
Davis, J
Clark, A
Weiss, S
Francomano, C
机构
[1] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Michigan, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[3] NCI, NIH, Bethesda, MD 20892 USA
[4] Proteomix Inc, San Diego, CA USA
关键词
D O I
10.1359/jbmr.1999.14.10.1649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pycnodyostosis, an autosomal recessive osteosclerosing skeletal disorder, has recently been shown to result from mutations in the cathepsin K gene. Cathepsin K, a lysosomal cysteine protease with an abundant expression in osteoclasts, has been implicated in osteoclast-mediated bone resorption and remodeling. DNA sequence analysis of the cathepsin K gene in a nonconsanguineous family demonstrated compound heterozygozity for mutations in two affected siblings. We have identified a missense mutation with a single base G-->A transition at cDNA nucleotide 236, resulting in conversion of a conserved glycine to a glutamine residue (G79E), The other mutation is an A-->T transition at nucleotide 154, leading to the substitution of a lysine residue by a STOP codon (K52X) predicting premature termination of the precursor cathepsin K polypeptide. Sequencing of genomic and cDNAs from the parents demonstrated that the missense mutation was inherited from the father and the nonsense mutation from the mother. Protein expression in both affected children was virtually absent, while in the parents was reduced by 50-80% compared with controls. The protein studies demonstrate that even significantly reduced cathepsin K levels do not have any phenotypic effect, whereas absent cathepsin K results in pycnodysostosis.
引用
收藏
页码:1649 / 1653
页数:5
相关论文
共 17 条
[1]  
ANDREN L., 1962, ACTA CHIR SCAND, V124, P496
[2]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[3]   HUMAN CATHEPSIN O2, A NOVEL CYSTEINE PROTEASE HIGHLY EXPRESSED IN OSTEOCLASTOMAS AND OVARY MOLECULAR-CLONING, SEQUENCING AND TISSUE DISTRIBUTION [J].
BROMME, D ;
OKAMOTO, K .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1995, 376 (06) :379-384
[4]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[5]   Structure and chromosomal assignment of the human cathepsin K gene [J].
Gelb, BD ;
Shi, GP ;
Heller, M ;
Weremowicz, S ;
Morton, C ;
Desnick, RJ ;
Chapman, HA .
GENOMICS, 1997, 41 (02) :258-262
[6]   LINKAGE OF PYCNODYSOSTOSIS TO CHROMOSOME 1Q21 BY HOMOZYGOSITY MAPPING [J].
GELB, BD ;
EDELSON, JG ;
DESNICK, RJ .
NATURE GENETICS, 1995, 10 (02) :235-237
[7]   Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency [J].
Gelb, BD ;
Shi, GP ;
Chapman, HA ;
Desnick, RJ .
SCIENCE, 1996, 273 (5279) :1236-1238
[8]  
HEDDIE D, 1968, DIS CHILD, V116, P70
[9]   MOLECULAR-CLONING OF HUMAN CDNA FOR CATHEPSIN-K - NOVEL CYSTEINE PROTEINASE PREDOMINANTLY EXPRESSED IN BONE [J].
INAOKA, T ;
BILBE, G ;
ISHIBASHI, O ;
TEZUKA, K ;
KUMEGAWA, M ;
KOKUBO, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (01) :89-96
[10]   A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis [J].
Johnson, MR ;
Polymeropoulos, MH ;
Vos, HL ;
deLuna, RIO ;
Francomano, CA .
GENOME RESEARCH, 1996, 6 (11) :1050-1055